Zimmer Biomet
808 hedge funds and large institutions have $22.5B invested in Zimmer Biomet in 2016 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 263 increasing their positions, 292 reducing their positions, and 29 closing their positions.
176% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 29
10% more funds holding in top 10
Funds holding in top 10: 20 → 22 (+2)
6% more funds holding
Funds holding: 765 → 808 (+43)
6% more call options, than puts
Call options by funds: $52.9M | Put options by funds: $50M
5% more capital invested
Capital invested by funds: $21.5B → $22.5B (+$1.01B)
10% less repeat investments, than reductions
Existing positions increased: 263 | Existing positions reduced: 292
2.43% less ownership
Funds ownership: 92.59% → 90.16% (-2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$175M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$103M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$92.4M |
| 4 |
Millennium Management
New York
|
+$91.6M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$78.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$453M |
| 2 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$442M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$161M |
| 4 |
Goldman Sachs
New York
|
-$135M |
| 5 |
SI
Sentry Investments
Toronto,
Ontario, Canada
|
-$66.6M |
ZBH Hedge Fund Activity: Q3 2016 in Review
808 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2016, worth a combined $22.5B — up 4.7% from $21.5B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new ZBH positions and 29 closed out — a net gain of 51 holders — while 263 added to existing stakes and 292 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $175M. The largest seller was Kohlberg Kravis Roberts & Co, exiting entirely with an estimated $453M sold.
- 808 institutional investors held Zimmer Biomet (ZBH) as of Q3 2016, up from 765 in Q2 2016.
- Funds reported $22.5B of Zimmer Biomet stock for Q3 2016, up 4.7% quarter-over-quarter.
- 80 funds opened new Zimmer Biomet positions in Q3 2016 and 29 closed out, a net change of +51 holders.
- The largest Zimmer Biomet buyer in Q3 2016 was Fidelity Investments, an estimated $175M added.
- The largest Zimmer Biomet seller in Q3 2016 was Kohlberg Kravis Roberts & Co, an estimated $453M sold.
Based on aggregated 13F filings for Q3 2016.